About Audrey Burton-Bethke

Articles by Audrey Burton-Bethke

MRD Testing in Newly Diagnosed Myeloma Patients: A Path to Better Outcomes
Apr 30, 2025
Military Service and MGUS Risk: What Veterans and Their Families Should Know
Apr 24, 2025
Beyond Standard Therapy: Novel Drug Classes Showing Promise for Relapsed Myeloma
Apr 15, 2025
Redefining Patient Evidence: Giving Myeloma Patients a True Voice
Mar 26, 2025
Do Patient Surveys Tell the Full Story? The Gap Between Data and Reality
Mar 19, 2025
A Myeloma Diagnosis: The Emotional and Physical Reality
Mar 12, 2025
Navigating Treatment in CLL: Understanding the Impact of Financial Strain and Quality of Life on Treatment Success
Mar 11, 2025
Processing the Emotional Side of Myeloma: The Story of Liz Levine
Mar 05, 2025
The Hidden Impact: How MDS-Related Transfusion Dependence Affects Caregivers Too
Feb 28, 2025
Register for the March 8th San Diego Myeloma Roundtable
Feb 20, 2025
How Groundbreaking Clinical Trials Changed The Way We Use MRD Testing in Multiple Myeloma
Feb 19, 2025
Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)
Feb 14, 2025
Assessing Responses of High-Risk CLL Patients to New Combo Therapy
Feb 14, 2025
Navigating Myeloma Together: Sholeh and Shwan
Feb 05, 2025
Understanding How CAR T Works in the Real World for Follicular Lymphoma
Feb 04, 2025
Real-World Data Shows Improved Outcomes for Black Patients with DLBCL
Feb 03, 2025
An Opportunity to Take Action: Regional Cure Teams
Jan 31, 2025
Se Revierte la Orden que Congelaba Temporalmente el Financiamiento del NIH
Jan 29, 2025
Astonishing Reversal on Cancer Research Funding Freeze
Jan 28, 2025
Is There Hope for Trispecific Antibodies in Myeloma Care?
Jan 23, 2025
A Better Understanding of Black Myeloma Biology (And How Racism Plays a Role in Outcomes)
Jan 22, 2025
Cecelia Butler Johnson: Two Decade Survivor of Myeloma and Breast Cancer
Jan 15, 2025
Breaking Barriers in AML Care: Addressing Survival Disparities in Young Adults
Jan 09, 2025
Venetoclax Plus 7+3 Chemotherapy: A Promising Induction Therapy for Newly Diagnosed AML
Jan 05, 2025